164 related articles for article (PubMed ID: 12352144)
1. Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects.
Skolnik PR; Rabbi MF; Mathys JM; Greenberg AS
J Acquir Immune Defic Syndr; 2002 Sep; 31(1):1-10. PubMed ID: 12352144
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression.
Kwon G; Xu G; Marshall CA; McDaniel ML
J Biol Chem; 1999 Jun; 274(26):18702-8. PubMed ID: 10373483
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma.
Meier CA; Chicheportiche R; Juge-Aubry CE; Dreyer MG; Dayer JM
Cytokine; 2002 Jun; 18(6):320-8. PubMed ID: 12160520
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
[TBL] [Abstract][Full Text] [Related]
5. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.
Jiang C; Ting AT; Seed B
Nature; 1998 Jan; 391(6662):82-6. PubMed ID: 9422509
[TBL] [Abstract][Full Text] [Related]
6. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
Aoun P; Simpkins JW; Agarwal N
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells.
Harris SG; Phipps RP
Immunology; 2002 Jan; 105(1):23-34. PubMed ID: 11849312
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
Camp HS; Li O; Wise SC; Hong YH; Frankowski CL; Shen X; Vanbogelen R; Leff T
Diabetes; 2000 Apr; 49(4):539-47. PubMed ID: 10871190
[TBL] [Abstract][Full Text] [Related]
9. Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages.
Asada K; Sasaki S; Suda T; Chida K; Nakamura H
Am J Respir Crit Care Med; 2004 Jan; 169(2):195-200. PubMed ID: 14563653
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
[TBL] [Abstract][Full Text] [Related]
11. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone.
Lappas M; Permezel M; Georgiou HM; Rice GE
J Clin Endocrinol Metab; 2002 Oct; 87(10):4667-72. PubMed ID: 12364456
[TBL] [Abstract][Full Text] [Related]
12. Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression.
Brunmair B; Gras F; Neschen S; Roden M; Wagner L; Waldhäusl W; Fürnsinn C
Diabetes; 2001 Oct; 50(10):2309-15. PubMed ID: 11574413
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects.
Hayes MM; Lane BR; King SR; Markovitz DM; Coffey MJ
J Biol Chem; 2002 May; 277(19):16913-9. PubMed ID: 11847231
[TBL] [Abstract][Full Text] [Related]
14. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869
[TBL] [Abstract][Full Text] [Related]
15. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells.
Padilla J; Kaur K; Cao HJ; Smith TJ; Phipps RP
J Immunol; 2000 Dec; 165(12):6941-8. PubMed ID: 11120820
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists.
Nie M; Corbett L; Knox AJ; Pang L
J Biol Chem; 2005 Jan; 280(4):2550-61. PubMed ID: 15531761
[TBL] [Abstract][Full Text] [Related]
18. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion.
Shimomura K; Shimizu H; Ikeda M; Okada S; Kakei M; Matsumoto S; Mori M
J Pharmacol Exp Ther; 2004 Sep; 310(3):1273-80. PubMed ID: 15201343
[TBL] [Abstract][Full Text] [Related]
19. Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2.
Ikeda Y; Sugawara A; Taniyama Y; Uruno A; Igarashi K; Arima S; Ito S; Takeuchi K
J Biol Chem; 2000 Oct; 275(42):33142-50. PubMed ID: 10930400
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
